Marinus Pharmaceuticals (NASDAQ:MRNS) Acquisition Completed by Immedica Pharma AB
On February 11, 2025, Immedica Pharma AB announced the successful completion of the acquisition of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) through its wholly-owned subsidiary, Matador Subsidiary, Inc. The acquisition was finalized following Immedica’s cash tender offer to acquire all outstanding shares of Marinus at $0.55 per share. The acquisition process involved Immedica acquiring all remaining […]
On February 11, 2025, Immedica Pharma AB announced the successful completion of the acquisition of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) through its wholly-owned subsidiary, Matador Subsidiary, Inc. The acquisition was finalized following Immedica’s cash tender offer to acquire all outstanding shares of Marinus at $0.55 per share. The acquisition process involved Immedica acquiring all remaining […]
